Contact the Editorial Desk

Editorial correspondence

This desk welcomes notes on the record itself: a citation quoted loosely, a study that has posted new results, a regulatory update that shifts an approval status, or a peer-reviewed study on semax, selank or DSIP that belongs on the references page. A correction that makes the record more accurate is the most valuable message this desk receives, and each one is read carefully.

The easiest notes to act on name three things: which page, the exact passage in question, and the supporting source — a DOI or PubMed identifier wherever available. In that shape, a proposed change can be checked against its source before anything is revised.

Editorial mailbox: editors@claritypeptidelabs.com

Beyond this desk's reach

So no message goes unanswered for the wrong reason, a few requests sit past what this desk can do. Because Clarity Peptide Labs reports the literature rather than practicing medicine or selling anything, it cannot:

• Weigh in on, endorse, or advise human use of semax, selank, DSIP, or any other peptide.
• Name a dose, schedule, or route for any individual.
• Judge whether a finding from a cited study applies to a specific person's situation.
• Sell, source, suggest, or help track down any compound from any supplier.
• Guide athletes under anti-doping rules — check the current WADA Prohibited List and consult a qualified authority directly.

Anyone with a genuine medical question about anxiety, sleep, or cognitive function should bring it to a licensed clinician in their own jurisdiction. Replies aren't guaranteed and can lag; the mailbox is checked periodically.